Skip to content

Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders.

Grace Blest‐hopley, Ben H Amit, Aisling O'Neill, Simon Ruffell

Frontiers in Psychiatry May 12, 2023 DOI: 10.3389/fpsyt.2023.1191970 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed
Topics Cannabis Psilocybin
Keywords Cannabinoids Psychedelics Hallucinogenic

Abstract

Editorial on the Research Topic Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders

Citations in the library

Explore topics